Medical Professionals

Our medicines >

We believe in the power of science in addressing some of the most challenging diseases of our time. Along with our long history of developing life-saving medicines, we have a promising pipeline that will shape the next generation of treatment options across various indications in five therapeutic areas.

Bristol Myers Squibb is active in five therapeutic areas

Cardiovascular diseases

Every day, we are committed to developing innovative treatments for patients affected by cardiovascular diseases.

Our focus includes both chronic and acute heart failure, particularly in patients with preserved ejection fraction. We also address Hypertrophic Cardiomyopathy (HCM), a condition that affects the heart muscle and belongs to the broader category of cardiovascular diseases (CVDs).

Cell Therapy

We are integrating CAR-T cell therapy as an essential part of our hematology focus, providing healthcare professionals with innovative solutions for treating patients with complex blood cancers.

Our focus encompasses treatment of both malignant and benign blood cancers, including CAR-T therapies for diseases such as lymphoma, multiple myeloma, leukemia and other complex hematological conditions.

Hematology

Hematology is a core pillar of Bristol Myers Squibb, where we have made significant progress. We are dedicated to developing breakthrough therapies to treat both malignant and benign blood disorders.

Our focus areas include myeloma, lymphoma, leukemia, and myeloid diseases such as myelodysplastic syndrome, beta-thalassemia, and myeloproliferative neoplasms

Immunology

Living with an immune-mediated disease is a debilitating reality for hundreds of millions of people around the world. While there has been progress with research and therapeutic options, patients may not respond to available treatments. Many continue to endure chronic symptoms and disease progression that can take a toll on their physical, emotional and social well-being, making simple tasks and daily life a challenge.

At Bristol Myers Squibb, we are pursuing pathbreaking science in Immunology to deliver meaningful solutions that address unmet needs in rheumatology, gastroenterology, dermatology and neurology. Our goal is to restore some of what immune-mediated diseases have taken away, empowering patients and their loved ones to take back their lives.

Oncology

Bristol Myers Squibb is a leader in the field of oncology with a comprehensive portfolio of both approved and investigational medicines.

Our efforts center on several key areas, starting with tumour biology and translational research to match the right treatments with the right patients at the right time. We are also developing new therapies that have the potential to transform standards of care, while exploring options for patients who do not currently benefit from checkpoint inhibitors. Additionally, we focus on IO-responsive tumours, working to enhance and prolong the body’s natural ability to recognise and eliminate cancer cells.

Medical information and services

Medical Information Contact Center and reporting side effects or product quality complaints.

medischeafdeling@bms.com

Visit our international website to report side effects or submit product quality complaints and questions about medical information in other countries.

Americas

Argentinië

Brazilië

Canada

Chili

Colombia

Mexico

Peru

Verenigde Staten

Azië

Australië

China

India

Japan

Korea

Nieuw-Zeeland

Taiwan

Thailand

Europa

Oostenrijk

België

Tsjechië

Denemarken

Finland

Frankrijk

Duitsland

Griekenland

Hongarije

Ierland

Italië

Luxemburg

Nederland

Noorwegen

Polen

Portugal

Roemenië

Spanje

Zweden

Zwitserland

Verenigd Koninkrijk

Midden-Oosten

Israël

Saoedi-Arabië

Turkije

Verenigde Arabische Emiraten

Overig

Overige markten

Our medicines >

Bristol Myers Squibb is active in five therapeutic areas

Cardiovascular diseases

Cell Therapy

Hematology

Immunology

Oncology

Medical information and services

Medical Information Contact Center and reporting side effects or product quality complaints.

medischeafdeling@bms.com

Clinical studies

Independent Research >

Clinical studies >

Researchers and partners >

Transparency >